Venture Capital Archives - Life Sciences Times

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

THIS WEEK'S STORIES

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

September 18, 2025

Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring

September 16, 2025

Mevion Medical Systems Secures FDA Clearance for MEVION S250-FIT Proton Therapy System

September 15, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Saisei Ventures Names James Feliciano as Venture Partner

Odyssey Therapeutics Secures $213 Million in Oversubscribed Series D to Advance Autoimmune Pipeline

LightSpun Raises $13M to Streamline Dental Insurance With AI

Boomerang Medical Secures $20 Million Series B to Advance Pivotal Neuromodulation Trial in Ulcerative Colitis

Enveda Secures $150 Million Series D to Reach Unicorn Status, Enrolls First Patient in Lead Trial, and Welcomes Mikael Dolsten to Board

Most Read

MoldCo Raises $8 Million to Expand Mold Detox Platform and Tackle Widespread Health Crisis

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

Tanner Health, Healthliant Ventures Partner with Incision USA to Enhance Operating Room Performance

EDITOR PICKS

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

THIS WEEK'S STORIES

Brainlab Wins FDA Clearance and Launches Spine Mixed Reality Navigation in the U.S.

Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring

Mevion Medical Systems Secures FDA Clearance for MEVION S250-FIT Proton Therapy System

POPULAR CATEGORY

ABOUT US

FOLLOW US